Title:
METHOD FOR PREDICTING SENSITIVITY TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2016/064231
Kind Code:
A1
Abstract:
The present invention relates to a method for predicting the sensitivity to treatment with vascular endothelial growth factor receptor (VEGFR) inhibitors, by using a biomarker. An effective means and anticancer therapy for cancer treatment of liver cancer are selected by predicting the effect of treatment with VEGFR inhibitors on liver cancer patients through the present invention, thereby increasing the treatment effect and minimizing the side effects of liver cancer treatment.
Inventors:
PARK JIN YOUNG (KR)
MOON YOUNG HO (KR)
KWON JUNG-HEE (KR)
KIM YUN SOO (KR)
KIM JU HYUN (KR)
CHOI DUCK JOO (KR)
MOON YOUNG HO (KR)
KWON JUNG-HEE (KR)
KIM YUN SOO (KR)
KIM JU HYUN (KR)
CHOI DUCK JOO (KR)
Application Number:
PCT/KR2015/011238
Publication Date:
April 28, 2016
Filing Date:
October 22, 2015
Export Citation:
Assignee:
CBSBIOSCIENCE INC (KR)
GIL MEDICAL CT (KR)
GIL MEDICAL CT (KR)
International Classes:
C12Q1/68; G01N33/15
Domestic Patent References:
| WO2013116735A1 | 2013-08-08 | |||
| WO2007109571A2 | 2007-09-27 | |||
| WO2014046623A1 | 2014-03-27 |
Other References:
KWON ET AL., PLOS ONE, vol. 8, no. 6, 2013, pages 1 - 10, XP055314085
HARDING ET AL.: "Systemic therapy for hepatoceiluiar carcinoma", CHINESE CLINICAL ONCOLOGY, vol. 2, no. 4, 2013, pages 1 - 14, XP055434011
See also references of EP 3211090A4
HARDING ET AL.: "Systemic therapy for hepatoceiluiar carcinoma", CHINESE CLINICAL ONCOLOGY, vol. 2, no. 4, 2013, pages 1 - 14, XP055434011
See also references of EP 3211090A4
Attorney, Agent or Firm:
AHN, So-Young (KR)
안소영 (KR)
안소영 (KR)
Download PDF: